| Literature DB >> 2367256 |
Abstract
Noncompliance in patients with epilepsy is a serious hindrance to successful treatment. It can result in increased healthcare costs and put both the patients and others around them at unnecessary risk. Noncompliance should be considered whenever a patient has (1) an unexpected increase in number of severity of seizures, (2) serum levels of anticonvulsant medications below the expected range, or (3) a change in medical reimbursement systems. Effective intervention strategies are based on assessment of life-style issues and possible barriers to compliance. Communication with the patient about medication regimens and the value of treatment is extremely important, and a real partnership between physician and patient is needed to set and achieve goals.Entities:
Mesh:
Substances:
Year: 1990 PMID: 2367256 DOI: 10.1080/00325481.1990.11716375
Source DB: PubMed Journal: Postgrad Med ISSN: 0032-5481 Impact factor: 3.840